GHC Stock Overview
Garofalo Health Care S.p.A. operates healthcare clinics in Italy.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Garofalo Health Care S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €4.65 |
| 52 Week High | €5.10 |
| 52 Week Low | €3.67 |
| Beta | 0.44 |
| 1 Month Change | -4.32% |
| 3 Month Change | -1.48% |
| 1 Year Change | 26.02% |
| 3 Year Change | -9.53% |
| 5 Year Change | 15.96% |
| Change since IPO | 30.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| GHC | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -1.7% | 5.4% | 1.7% |
| 1Y | 26.0% | 0.6% | 2.3% |
Return vs Industry: GHC exceeded the German Healthcare industry which returned 1.9% over the past year.
Return vs Market: GHC exceeded the German Market which returned 2.2% over the past year.
Price Volatility
| GHC volatility | |
|---|---|
| GHC Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: GHC has not had significant price volatility in the past 3 months.
Volatility Over Time: GHC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 2,069 | Maria Garofalo | www.garofalohealthcare.com |
Garofalo Health Care S.p.A. operates healthcare clinics in Italy. It offers services in the areas of high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and nutritional rehabilitation. The company also operates centers for patients in coma and persistent vegetative states; and psychiatric and diagnostic centers.
Garofalo Health Care S.p.A. Fundamentals Summary
| GHC fundamental statistics | |
|---|---|
| Market cap | €418.09m |
| Earnings (TTM) | €20.80m |
| Revenue (TTM) | €368.70m |
20.1x
P/E Ratio1.1x
P/S RatioIs GHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GHC income statement (TTM) | |
|---|---|
| Revenue | €368.70m |
| Cost of Revenue | €287.04m |
| Gross Profit | €81.66m |
| Other Expenses | €60.86m |
| Earnings | €20.80m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 22.15% |
| Net Profit Margin | 5.64% |
| Debt/Equity Ratio | 76.1% |
How did GHC perform over the long term?
See historical performance and comparison